The correct method is to start low and titrate the dose up according to the protocol's schedule
And try not to skip strength training
Use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of pancreatitis (adjusted HR, 9.09 [95% CI, 1.25-66.00]), bowel obstruction (HR, 4.22 [95% CI, 1.02-17.40]), and gastroparesis (HR, 3.67 [95% CI, 1.15-11.90) but not biliary disease (HR, 1.50 [95% CI, 0.89-2.53])
Pathophysiology of Facial Volume Loss with GLP-1 Medications The use of semaglutide and similar compounds leads to a reduction in overall body fat , including subcutaneous facial fat
However, through ongoing dialogue and support, she gained confidence in preparing meals that were both healing and aligned with her mothers preferences